Analysis of Tumor Markers in the Cytological Fluid Obtained from Computed Tomography-Guided Needle Aspiration Biopsy for the Diagnosis of Non-small Cell.

Slides:



Advertisements
Similar presentations
The Accuracy of Frozen Section Diagnosis of Pulmonary Nodules: Evaluation of Inflation Method during Intraoperative Pathology Consultation with Cryosection.
Advertisements

Volume 119, Issue 4, Pages (April 2001)
Neoplastic Fever Caused by Lung Cancer
Sukki Cho, MD, Kyung-Min Ryu, MD, Yoon-Jin Hwang, MD, Eung Bae Lee, MD 
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.
The Signature from Messenger RNA Expression Profiling Can Predict Lymph Node Metastasis with High Accuracy for Non-small Cell Lung Cancer  Naeyun Choi,
Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation.
Detection of ALK Gene Rearrangement in Non-small Cell Lung Cancer: A Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization.
A novel detection method of non–small cell lung cancer using multiplexed bead-based serum biomarker profiling  Hyun Joo Lee, MD, PhD, Young Tae Kim, MD,
Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.
Coronary Computed Tomography Angiography for Selecting Coronary Artery Bypass Graft Surgery Candidates  Soo-Yeon Kim, MD, Hye-Jeong Lee, MD, PhD, Young.
The BIM Deletion Polymorphism and its Clinical Implication in Patients with EGFR- Mutant Non–Small-Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors 
Long-Term Follow-up of Small Pulmonary Ground-Glass Nodules Stable for 3 Years: Implications of the Proper Follow-up Period and Risk Factors for Subsequent.
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Incidence of Brain Metastasis at the Initial Diagnosis of Lung Squamous Cell Carcinoma on the Basis of Stage, Excluding Brain Metastasis  Hyun Lee, MD,
The Presence of Mutations in Epidermal Growth Factor Receptor Gene Is Not a Prognostic Factor for Long-Term Outcome after Surgical Resection of Non–Small-Cell.
P2-090: Expression of cellular retinol binding protein-1 is associated with poor prognosis of stage I non-small cell lung cancer  Moo Suk Park, Yoon Soo.
Analysis of Unexpected Conversion to Thoracotomy During Thoracoscopic Lobectomy in Lung Cancer  Chun Sung Byun, MD, Sungsoo Lee, MD, PhD, Dae Joon Kim,
First-Line Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status  Young Joo Lee, MD, Heung Tae Kim, MD,
P Is It Necessary to Repeat Lung Cancer Screening with Low-Dose CT(LDCT) in Female Never Smokers?  Hyae Young Kim, Kyu-Won Jung, Kun Young Lim,
Late Referral to Palliative Care Services in Korea
Erlotinib Monotherapy for Stage IIIB/IV Non-small Cell Lung Cancer: A Multicenter Trial by the Korean Cancer Study Group  Ji Eun Uhm, MD, MSc, Byeong-Bae.
Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma  Ho Yun Lee, MD, PhD, So Won Lee, MD, Kyung.
Successful Treatment with Crizotinib in Mechanically Ventilated Patients with ALK Positive Non–Small-Cell Lung Cancer  Hee Kyung Ahn, MD, Kyeongman Jeon,
Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma  So Hee Song, MD, Hyunjin Park, PhD, Geewon Lee, MD,
Adequacy Criteria of Rapid On-Site Evaluation for Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: A Simple Algorithm to Assess the Adequacy.
Positron Emission Tomography-Computed Tomography for Postoperative Surveillance in Non-Small Cell Lung Cancer  Se Hoon Choi, MD, Young Tae Kim, MD, PhD,
Neoplastic Fever Caused by Lung Cancer
Contributions of bronchoscopic microsampling in the supplemental diagnosis of small peripheral lung carcinoma  Masazumi Watanabe, MD, PhD, Akitoshi Ishizaka,
A New KIT Gene Mutation in Thymic Cancer and a Promising Response to Imatinib  Sung Hee Lim, MD, Ji-Yun Lee, MD, Jong-Mu Sun, MD, PhD, Kyoung-Mee Kim,
Anaplastic Lymphoma Kinase Translocation: A Predictive Biomarker of Pemetrexed in Patients with Non-small Cell Lung Cancer  Jeong-Ok Lee, MD, Tae Min.
Total Lesion Glycolysis in Positron Emission Tomography Can Predict Gefitinib Outcomes in Non–Small-Cell Lung Cancer with Activating EGFR Mutation  Bhumsuk.
Clinical Outcomes and Prognosis of Recurrent Thymoma Management
Atypical Thymoma (World Health Organization Type B3) with Neuroendocrine Differentiation Combined with Hyperparathyroidism  Hyun Sik Park, MD, Sang Wha.
High MET Gene Copy Number Leads to Shorter Survival in Patients with Non-small Cell Lung Cancer  Heounjeong Go, MD, Yoon Kyung Jeon, MD, PhD, Hyo Jin.
Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma  Ho Yun Lee, MD, PhD, So Won Lee, MD, Kyung.
Association between Genetic Variants in Pre-MicroRNAs and Survival of Early-Stage NSCLC  Mi Jeong Hong, MS, Yi Young Choi, MS, Ji-Ae Jang, MS, Hye-Jin.
A Different Method in Diagnosis of Multiple Primary Lung Cancer
Frequency of Lymph Node Metastasis According to the Size of Tumors in Resected Pulmonary Adenocarcinoma with a Size of 30 mm or Smaller  Yangki Seok,
Outcomes of Mediastinoscopy and Surgery with or without Neoadjuvant Therapy in Patients with Non-small Cell Lung Cancer Who are N2 Negative on Positron.
Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response 
A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib  Yoon Jin Cha, MD, PhD, Byoung Chul.
Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS 
Respiratory dynamic magnetic resonance imaging for determining aortic invasion of thoracic neoplasms  Yoo Jin Hong, MD, Jin Hur, MD, Hye-Jeong Lee, MD,
Value of Combined Interpretation of Computed Tomography Response and Positron Emission Tomography Response for Prediction of Prognosis After Neoadjuvant.
ALK Translocation in Non-small Cell Lung Cancer with Adenocarcinoma and Squamous Cell Carcinoma Markers  Samuel J. Klempner, MD, David W. Cohen, MD, Daniel.
An Unmet Need in the WHO 2015 Biopsy Classification: Poorly Differentiated NSCCs with Positive Neuroendocrine Markers  Jules L. Derks, MD  Journal of.
Osimertinib for Epidermal Growth Factor Receptor Mutation–Positive Lung Adenocarcinoma That Transformed to T790M-Positive Squamous Cell Carcinoma  Naoyuki.
Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small Cell Lung Cancer  Hong Kwan Kim, MD, Yong Soo Choi,
A Case of Pemetrexed-Induced Acute Lung Injury in Non-small Cell Lung Cancer  Hye Ok Kim, MD, Sung Yong Lee, MD, PhD, Jae Jeong Shim, MD, PhD, Kyung Ho.
MTP13-01: Indications and limitations of bronchoscopy
Forced Expiratory Volume in One Second as a Prognostic Factor in Advanced Non- small Cell Lung Cancer  Jin Hwa Lee, MD, PhD, Eun Mi Song, MD, Yun Su Sim,
Peripheral Direct Adjacent Lobe Invasion Non-small Cell Lung Cancer Has a Similar Survival to That of Parietal Pleural Invasion T3 Disease  Hao-Xian Yang,
Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival  Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,
Endobronchial Ultrasound versus Mediastinoscopy for Mediastinal Nodal Staging of Non–Small-Cell Lung Cancer  Sang-Won Um, MD, PhD, Hong Kwan Kim, MD,
Impact of Chronic Obstructive Pulmonary Disease on the Mortality of Patients with Non– Small-Cell Lung Cancer  Seung Jun Lee, MD, Jinwoo Lee, MD, Young.
Jie Huang, Juan Peng, Linlang Guo, MD, PhD 
Association Between Age at Diagnosis and the Presence of EGFR Mutations in Female Patients with Resected Non-small Cell Lung Cancer  Yoon Hee Choi, MD,
Genetic Changes in Squamous Cell Lung Cancer: A Review
EGFR Mutations in Squamous Cell Lung Cancer in Never-Smokers
Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer  Eun Young Kim, MD, Young Saing Kim, MD, Inkeun Park, MD,
Combined Evaluation of Postoperative Serum Levels of Carcinoembryonic Antigen Less than or Equal to 2.5 ng/ml and Absence of Vascular Invasion may Predict.
Validity of International Association for the Study of Lung Cancer Proposals for the Revision of N Descriptors in Lung Cancer  Jin Gu Lee, MD, Chang Young.
P Post-Recurrence Survival Analysis of Stage I Non-Small Cell Lung Cancer: Prognostic Significance of Local Treatment  Kanghoon Lee, Hyeong Ryul.
Long-Term Follow-Up of Ground-Glass Nodules After 5 Years of Stability
A Functional Polymorphism on Chromosome 15q25 Associated with Survival of Early Stage Non–Small-Cell Lung Cancer  Guang Jin, MD, PhD, Eun Young Bae, BS,
Who should decide margin length in pulmonary excision of lung cancer?
Sleeve Lobectomy as an Alternative Procedure to Pneumonectomy for Non-small Cell Lung Cancer  Joon Suk Park, MD, Hee Chul Yang, MD, Hong Kwan Kim, MD,
A Review of First-Line Treatment for Small-cell Lung Cancer
Presentation transcript:

Analysis of Tumor Markers in the Cytological Fluid Obtained from Computed Tomography-Guided Needle Aspiration Biopsy for the Diagnosis of Non-small Cell Lung Cancer  Yoo Jin Hong, MD, Jin Hur, PhD, Hye-Jeong Lee, PhD, Ji Eun Nam, MD, Young Jin Kim, PhD, Hua Sun Kim, MD, Hee Yeong Kim, MD, Se Kyu Kim, PhD, Joon Chang, PhD, Joo-Hang Kim, PhD, Kyung Young Chung, PhD, Byoung Wook Choi, PhD, Kyu Ok Choe, PhD  Journal of Thoracic Oncology  Volume 6, Issue 8, Pages 1330-1335 (August 2011) DOI: 10.1097/JTO.0b013e31822462b1 Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Receiver operating characteristic (ROC) curves of the three cytologic tumor markers cytokeratin 19 fragments (CYFRA 21-1) (A), carcinoembryonic antigen (CEA) (B), and squamous cell carcinoma (SCC) (C) for distinguishing benign lesions from malignant lesions. The best cutoff values for the tumor markers were 15.7 ng/ml for CYFRA 21-1, 0.6 ng/ml for CEA, and 0.86 ng/ml for SCC. Journal of Thoracic Oncology 2011 6, 1330-1335DOI: (10.1097/JTO.0b013e31822462b1) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.